Italian National Consensus Conference on Prostate Cancer Screening (Florence,May 17,2003) - Final Consensus Document

Shibata A. , Whittemore A.S. Prostate cancer incidence and mortality in the United States and the United Kingdom. J Natl Cancer Inst 2001; 93: 1109–10.

Ciatto S. , Zappa M. , Bonardi R. , Gervasi G. Prostate cancer screening: the problem of overdiagnosis and lessons to be learned from breast cancer screening. Eur J Cancer 2000; 36: 1347–50.

Holund B. Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol 1980; 14: 29–43.

de Koning H.J. , Auvinen A. , Berenguer-Sanchez A. . Large scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary Cancer trial. Int J Cancer 2002; 97: 237–44.

Bartsch G. , Horniger W. , Klocker H. . Prostate cancer mortality after introduction of prostate specific antigen mass screening in the federal state of Tyrol, Austria. Urology 2002; 58: 417–24.

Labrie F. , Candas B. , Dupont A. . Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomised Controlled Trial. The Prostate 1999; 38: 83–91.

Lu-Yao G. , Albertsen P.C. , Stanford J.L. , Stukel T.A. , Walker-Crkery E.S. , Barry M.J. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ 2002; 325: 740.

Zappa M. , Ciatto S. , Bonardi R. , Mazzotta A. Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study. Ann Oncol 1998; 9: 1297–300.

Ciatto S. Screening for prostate cancer by PSA determination: a time for caution. Int J Biol Markers 2000; 15: 285–7.

Holmberg L. , Bill-Axelson A. , Helgesen F. . A randomised trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781–9.

Ciatto S. , Bonardi R. , Mazzotta A. , Zappa M. Diagnosi precoce del carcinoma prostatico. In: Raccomandazioni per gli screening in oncologia. Roma: Lega Italiana per la Lotta contro i Tumori, 1996; 109–18.

Consenso sugli screening in oncologia: indirizzo per la ricerca e raccomandazioni al servizio Sanitario Nazionale. Consiglio Nazionale delle Ricerche - Associazione Italiana per la Ricerca sul Cancro. Roma, 1996; 123–7.

Linee Guida per il Carcinoma Prostatico: 1. Diagnosi, Stadiazione e Follow Up. AURO (Associazione Urologi Italiani), 1998; 88–93.

Denis L.J. , Murphy G.P. , Schroeder F. Report of the consensus workshop on screening and global strategy for prostate cancer. Cancer 1995; 75: 1187–207.

U.S. Preventive Services Task Force. Screening for prostate cancer: recommendations and rationale. Ann Intern Med 2002; 137: 915–6.

Advisory Committee on Cancer Prevention. Position paper: Recommendations on cancer screening in the European Union. Eur J Cancer 2000; 36: 1473–8.

Cooper G.S. , Yuan Z. , Jethva R.N. , Rimm A.A. Determination of county-level prostate carcinoma incidence and detection rates with Medicare claims data. Cancer 2001; 92: 102–9.

Melia J. , Moss S. Survey of the rate of PSA testing in general practice. Br J Cancer 2001; 85: 656–7.